EFPIA is delighted to announce the appointment of three key roles on the EFPIA Board.

Stefan Oschmann, Chairman of the Executive Board and CEO of Merck, has been elected to the role of President of EFPIA, replacing outgoing President Joe Jimenez, CEO of Novartis.

Olivier Brandicourt, CEO of Sanofi, and Jean-Christophe Tellier, CEO and Chairman of the Executive Committee of UCB, have been appointed as Vice Presidents, working with Mr Oschmann and the rest of the EFPIA Board to address the opportunities that arise for the industry in Europe.